|
|
Durect News (NASDAQ:DRRX)
| Latest Durect News Headlines | | Date | Time | Source | | | 11/03/2008 | 4:05PM | PRNUS | DURECT Corporation Announces Third Quarter 2008 Financial Results
CUPERTINO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today financial results for the three months ended September 30, 2008. Total revenues were $6.6 million for the three months ended September 30, 2008, compared to $4.9 million for the same period in 2007. Net loss for the... More...>> |
| 10/29/2008 | 7:00AM | PRNUS | DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective
CUPERTINO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that the previously announced development and license agreement with Alpharma Ireland Limited, an affiliate of Alpharma Inc. (NYSE:ALO), granting such party the exclusive worldwide rights to develop and commercialize... More...>> |
| 10/28/2008 | 9:00AM | PRNUS | DURECT Corporation to Participate in Upcoming Healthcare Conferences
CUPERTINO, Calif., Oct. 28 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that management is scheduled to present at the following upcoming healthcare conferences in New York, NY.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)
-- Oppenheimer 19th Annual Healthcare Conference... More...>> |
| 10/27/2008 | 8:50AM | PRNUS | DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call
CUPERTINO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- In conjunction with DURECT Corporation's (NASDAQ:DRRX) third quarter 2008 financial results press release, you are invited to listen to the conference call that will be broadcast live over the Internet on Monday, November 3, 2008 at 4:30 p.m. Eastern Time (1:30 p.m... More...>> |
| 10/21/2008 | 9:00AM | PRNUS | Beacon Equity Issues Technical Trade Alerts on Market Movers: INCY, DRRX, MDRX, NKTR, PRGN, AFFX
DALLAS, Oct. 21 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today.
Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m
Today's Trade Alerts include: Incyte Corp. (NASDAQ:INCY), Durect Corp. (NASDAQ:DRRX), Allscripts... More...>> |
| 09/22/2008 | 7:00AM | PRNUS | Alpharma to Develop and Commercialize DURECT's ELADUR(TM) Pain Patch
CUPERTINO, Calif., Sept. 22 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that it has entered into a development and license agreement with an affiliate of Alpharma Inc. (NYSE:ALO) granting such party the exclusive worldwide rights to develop and commercialize ELADUR(TM), DURECT's investigational... More...>> |
| 09/15/2008 | 8:45AM | PRNUS | DURECT Corporation Presenting at the 2008 UBS Global Life Sciences Conference
CUPERTINO, Calif., Sept. 15 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that it will present at the 2008 UBS Global Life Sciences Conference being held at the Grand Hyatt Hotel in New York. Matthew J. Hogan, Chief Financial Officer, will be presenting at the conference on September 22... More...>> |
| 08/27/2008 | 2:56PM | PRNUS | DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology
CUPERTINO, Calif., Aug. 27 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) today reported that Pain Therapeutics (NASDAQ:PTIE), its licensee, has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for an abuse-resistant opioid pain drug candidate based on... More...>> |
| 08/12/2008 | 2:18PM | PRNUS | REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted
CUPERTINO, Calif., Aug. 12 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that the US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) of REMOXY(R) and granted Priority Review. The FDA typically grants Priority Review to drug candidates that have the potential... More...>> |
| 08/05/2008 | 4:15PM | PRNUS | DURECT Corporation Announces Second Quarter 2008 Financial Results
CUPERTINO, Calif., Aug. 5 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today financial results for the three months ended June 30, 2008. Total revenues were $6.3 million for the three months ended June 30, 2008, compared to $13.4 million for the same period in 2007. Net loss for the three months... More...>> |
| 07/30/2008 | 8:50AM | PRNUS | DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call
CUPERTINO, Calif., July 30 /PRNewswire-FirstCall/ -- In conjunction with DURECT Corporation's (NASDAQ:DRRX) second quarter 2008 financial results press release, you are invited to listen to the conference call that will be broadcast live over the Internet on Wednesday, August 6, 2008 at 9:00 a.m. EDT (6:00 a.m. PDT).
(Logo:... More...>> |
| 06/30/2008 | 9:00AM | PRNUS | ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
CUPERTINO, Calif., June 30 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that the US Food and Drug Administration (FDA) has granted to DURECT orphan drug designation for bupivacaine for relief of persistent pain associated with post-herpetic neuralgia (PHN). Bupivacaine is the active pharmaceutical... More...>> |
| 06/17/2008 | 9:00AM | PRNUS | DURECT's Convertible Notes Exchange into Equity at Maturity
CUPERTINO, Calif., June 17 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that the remaining $23.6 million in 6.25% Convertible Notes had been exchanged by the holders at their maturity date into approximately 7.5 million shares, per the original terms of the indenture. As a result, DURECT... More...>> |
| 06/10/2008 | 5:42PM | PRNUS | New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone)
CUPERTINO, Calif., June 10 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that a New Drug Application (NDA) for Remoxy(TM) (ORADUR(TM)-based oxycodone) has been submitted to the U.S. Food and Drug Administration (FDA). Remoxy, an investigational drug, is a long acting oral formulation of... More...>> |
| 06/06/2008 | 8:45AM | PRNUS | DURECT Corporation to Participate in Upcoming Healthcare Conferences
CUPERTINO, Calif., June 6 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that management is scheduled to present at three upcoming life sciences conferences in New York, NY.
-- Needham & Company's Biotechnology and Medical Technology Conference on
Thursday, June 12th at 11:30 a.m... More...>> |
| 05/21/2008 | 9:00AM | PRNUS | DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
CUPERTINO, Calif., May 21 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that it will present at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference being held at the Waldorf Hilton Hotel in London. Matthew J. Hogan, Chief Financial Officer, will be presenting at the conference... More...>> |
| 05/07/2008 | 4:05PM | PRNUS | DURECT Corporation Announces First Quarter 2008 Financial Results
CUPERTINO, Calif., May 7 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today financial results for the three months ended March 31, 2008. Total revenues were $6.4 million for the three months ended March 31, 2008, compared to $5.7 million for the same period in 2007. Net loss for the three months... More...>> |
| 04/29/2008 | 8:45AM | PRNUS | DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call
CUPERTINO, Calif., April 29 /PRNewswire-FirstCall/ -- In conjunction with DURECT Corporation's (NASDAQ:DRRX) first quarter 2008 financial results press release, you are invited to listen to the conference call that will be broadcast live over the Internet on Wednesday, May 7th, 2008 at 4:30 p.m. EDT (1:30 PM PDT).
(Logo:... More...>> |
| 04/22/2008 | 9:00AM | PRNUS | DURECT to Participate in Morgan Stanley Global Healthcare Conference
CUPERTINO, Calif., April 22 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that James Brown, President and Chief Executive Officer, will be presenting at the Morgan Stanley 2008 Global Healthcare Unplugged Conference on April 30, 2008 at 8:30 a.m. ET. The conference is being held at the... More...>> |
| 04/07/2008 | 5:47PM | PRNUS | DURECT Provides Update on CHRONOGESIC(R) Research Program
CUPERTINO, Calif., April 7, 2008 /PRNewswire-FirstCall/ -- DURECT Corporation (NASDAQ:DRRX) announced today that Endo Pharmaceuticals has stated that it intends to return the rights to CHRONOGESIC(R) licensed from DURECT Corporation for the U.S. and Canada. CHRONOGESIC is a product candidate consisting of a sufentanil... More...>> |
|
|
|